Rubella Diagnostic Testing Market Forecast to 2019-2024 by Industry Share, Size, Growth Rate, and Regional Analysis by Top Key Players

Press Release

Rubella Diagnostic Testing

Report Titled: “Rubella Diagnostic Testing Market – Growth, Trends, and Forecast (2019 – 2024)

The Research Report on “Rubella Diagnostic Testing Market” 2019 report includes every aspect of the Rubella Diagnostic Testing industry along with the progress performance. Rubella Diagnostic Testing Market report presents an analysis of market size, share, and growth, trends, and price structure, statistical and detailed data of the Rubella Diagnostic Testing industry. Additionally, Rubella Diagnostic Testing Market 2019 research report offers key analysis on the industry status of the Rubella Diagnostic Testing producers with market size, growth, share, trends as well as business price structure.

The Rubella Diagnostic Testing Market report is a professional and detailed study on the Rubella Diagnostic Testing business. Rubella Diagnostic Testing market to predict future market directions between the forecast periods from 2019 to 2024 providing you with vital data for your business decisions.

Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14244600

Scope of the Report:

  • As per the , rubella diagnostic testing refers to the detection of the rubella virus. These tests are prescribed for pregnant women and may also be performed on babies born with congenital defects. Rubella can be detected with the help of various diagnostic tests, such as latex agglutination, enzyme immunoassay, radioimmunoassay (RIA), and fluorescent immunoassay (FIA), among others.

    Market Overview:

  • The major factors for the growth of the rubella diagnostic testing market include the government initiatives to curb the rubella virus, increasing incidences of rubella, and the introduction of advanced point-of-care diagnostic technologies, which are expected to boost the overall growth of the market over the forecast period.
  • There has been an increase in the number of incidences of rubella across the world. Rubella is an acute, contagious viral infection that causes a mild fever and rash illness in children and adults. Infection during pregnancy, especially during the first trimester, can result in miscarriage, stillbirth, fetal death, or infants with congenital malformations. According to the data published by the Centers for Disease Control and Prevention (CDC), rubella is a global health concern, and every year, more than 100,000 cases of congenital rubella syndrome (CRS) are reported, globally. A woman infected with rubella during the first three months of pregnancy has up to a 90% chance of giving birth to a baby with congenital rubella syndrome.
  • In 2015, the WHO Region of the Americas became the first in the world to be declared free of endemic transmission of rubella. Rubella can be prevented with the measles, mumps, and rubella (MMR) vaccine. Governments in various countries across the world are conducting vaccination programs to curb the incidences of rubella. As per the estimates of WHO, as of December 2016, 152 out of 194 countries had introduced rubella vaccines and reported rubella cases declined by 97%, from 670,894 cases in 102 countries, in 2000, to 22,361 cases in 165 countries in 2016.
  • On the other hand, as per the Global Vaccine Action Plan (GVAP) Assessment report, rubella control is lagging, with 42 countries yet to introduce the vaccine.

    Rubella Diagnostic Testing Report Also Covers Offer for New Project Includes:

    • Market Entry Strategies
    • Countermeasures of Economic Impact
    • Marketing Channels
    • Feasibility Studies of New Project Investment
    • Research Conclusions of the Rubella Diagnostic Testing Industry

    The report provides key statistics on the market status of the Rubella Diagnostic Testing Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Rubella Diagnostic Testing.

    Enquire Before Purchasing this Report – https://www.industryresearch.co/enquiry/pre-order-enquiry/14244600

    Rubella Diagnostic Testing Market Report Also Covers Marketing Strategy Analysis, Top Manufacturers:

  • Abbott
  • Beckman Coulter Inc.
  • Bio Rad Laboratories Inc.
  • Biokit SA
  • bioMérieux SA
  • F. Hoffmann
  • La Roche Ltd
  • Ortho Clinical Diagnostics
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific
  • ZEUS Scientific Inc.

    Key Market Trends:

    Enzyme Immunoassay Segment under Testing Technique Accounted for the Largest Share in the Global Market

    The detection of rubella-specific immunoglobulin M (IgM) in serum is the standard test for the rapid laboratory diagnosis of rubella. IgM testing is the most commonly performed testing technique using commercial enzyme immunoassay (EIA) kits. The blood test detects antibodies that are made by the immune system to kill the rubella virus, and these antibodies remain in the bloodstream for years. The segment is expected to account for the largest market share, owing to the rising incidences of rubella.

    Asia-Pacific Accounted for the Highest Growth Rate in the Global Market

    The Asia-Pacific segment, by geography, was found to register the fastest growth rate for the rubella diagnostic testing market and is expected to show a similar trend over the forecast period, without significant fluctuations. The Asia-Pacific region holds the highest market share, owing to the presence of larger untapped opportunities, a lack of awareness in some countries, and government initiatives to curb the disease incidence. As per the Global Vaccine Action Plan (GVAP) Assessment report 2017, 42 countries have not yet introduced the vaccine, and two regions, Africa and the Eastern Mediterranean, have not yet set rubella elimination or control targets. Such regions are expected to face high incidences of rubella, which may further drive the growth of the market.

    Purchase this Report (Price 4250 USD for Single User License) – https://www.industryresearch.co/purchase/14244600

    Detailed TOC of Rubella Diagnostic Testing Market Report are:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Government Initiatives to Curb Rubella Virus
    4.2.2 Increasing Incidences of Rubella
    4.2.3 Introduction of Advance Point-of-care Diagnostic Technologies
    4.3 Market Restraints
    4.3.1 Lack of Awareness among Developing Regions
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products and Services
    4.4.5 Intensity of Competitive Rivalry

    5.1 Testing Technique
    5.1.1 Latex Agglutination
    5.1.2 Enzyme Immunoassay (EIA)
    5.1.3 Radioimmunoassay (RIA)
    5.1.4 Fluorescent Immunoassay (FIA)
    5.1.5 Other Testing Techniques
    5.2 Application
    5.2.1 Hospitals
    5.2.2 Laboratories
    5.2.3 Other Applications
    5.3 Geography
    5.3.1 North America US Canada Mexico
    5.3.2 Europe Germany UK France Italy Spain Rest of Europe
    5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
    5.3.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
    5.3.5 South America Brazil Argentina Rest of South America

    6.1 Company Profiles
    6.1.1 Abbott
    6.1.2 Beckman Coulter Inc.
    6.1.3 Bio Rad Laboratories Inc.
    6.1.4 Biokit SA
    6.1.5 bioMérieux SA
    6.1.6 F. Hoffmann-La Roche Ltd
    6.1.7 Ortho Clinical Diagnostics
    6.1.8 Siemens Healthcare GmbH
    6.1.9 Thermo Fisher Scientific
    6.1.10 ZEUS Scientific Inc.



    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

  • Related Articles